Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NAD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
High purity rhodium catalyst synthesis via patent CN111087274A. Offers improved yield and supply chain stability for fine chemical manufacturing.
Patent CN107557412B details a continuous immobilized enzyme method for NADPH synthesis, offering high purity and cost reduction in biopharmaceutical manufacturing.
Patent CN107557412A details immobilized enzyme catalysis for NADPH. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN119661452B reveals vanadium-catalyzed triazole synthesis using biomass. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113185431B reveals a chromium-free route for Menadione Sodium Bisulfite using air oxidation, offering significant cost reduction and supply chain stability for feed additive manufacturers.
Novel patent CN105294678A details improved Nadifloxacin synthesis. Offers higher yield and industrial scalability for pharmaceutical supply chains.
Novel synthetic route for fexofenadine avoiding isomer separation. High yield, simple process, cost-effective manufacturing for pharmaceutical intermediates.
Novel Ni/C catalyst method for nadifloxacin intermediate. High yield, green process, reliable supply chain partner for pharmaceutical manufacturing.
Patent CN102070490B reveals a novel route for fexofenadine intermediates, offering high purity and significant cost reduction in API manufacturing for global supply chains.
Patent CN113185433A discloses a green synthesis of Menadione Sodium Bisulfite using benzene and lactone, eliminating chromium waste and reducing manufacturing costs significantly.
Advanced base-catalyzed synthesis of Fexofenadine intermediate CN101585762A offers high purity, reduced costs, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN116063358B details aqueous synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN106220586A details a metal-free synthesis of 5-amino-1,2,4-selenadiazole derivatives using selenium powder, offering high yields and supply chain reliability for pharmaceutical intermediates.
Novel vanadyl-catalyzed oxidation method for 6-hydroxy-2H-pyran-3-one. Mild conditions, high yield, scalable for pharmaceutical intermediates supply chain.
Patent CN104024201B details a selective vanadium-catalyzed oxidation of nerolidol to farnesal, offering cost reduction in pharma intermediate manufacturing and enhanced supply reliability.